About Agreement Glenmark Life Sciences (GLS) has signed a Master Supply Agreement (MSA) with a Japanese innovator pharmaceutical company with a global presence in Europe, the United States and Asia. Under the aegis of the Master Supply Agreement, Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the …